Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 23, 2001Neurology

Use of anti-ICAM-1 therapy in ischemic stroke

View Full Paper
Ask AI
Bookmark
Share

Authors

EIEnlimomab Acute Stroke Trial InvestigatorsThe University of Texas Health Science Center at San Antonio

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Enlimomab Acute Stroke Trial Investigators (2001) studied this question.

synapsesocial.com/papers/69d6f30675cae9790bed8e89https://doi.org/10.1212/wnl.57.8.1428
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons.1991 · 770 citations
  2. 2Anti‐ICAM‐1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat1994 · 364 citations
  3. 3Spontaneous Middle Cerebral Artery Reperfusion in Ischemic Stroke1995 · 126 citations
  4. 4Brain injury, edema, and vascular permeability changes induced by oxygen‐derived free radicals1984 · 387 citations
  5. 5Early Polymorphonuclear Leukocyte Accumulation Correlates with the Development of Posttraumatic Cerebral Edema in Rats1990 · 198 citations